[1]
M. Zheng, N. Zhou, L. Ma, and W. Jin, “Amrubicin therapy improves patients with refractory small-cell lung cancer: A single-arm confirmatory Chinese clinical study”, Bangladesh J Pharmacol, vol. 11, no. 3, pp. 564–569, Jun. 2016.